Sign in
4

Changes in Ownership

ADC Therapeutics SA Filed Acc 0001628280-26-040493

Director gave up 12,600 shares (to pay taxes)

  • Director acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Azelby Robert Director 2026-06-01 Grant or award +45,000 125,405 D
Azelby Robert Director 2026-06-03 Shares withheld for taxes −12,600 $3.08 $38,808 112,805 D
Loading xslF345X06/wk-form4_1780520620.xml…